We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current OBI market cap is 22.88M. The company's latest EPS is CAD -0.0699 and P/E is -1.18.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 373k | 464k | 1.79M | 2.57M | 638k |
| Operating Income | -16.53M | -14.03M | -15.87M | -17.52M | -18.76M |
| Net Income | -16.85M | -13.9M | -16.27M | -50.09M | -19.37M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 4.5M | 2.91M | 2.64M | 34.14M | 16.57M |
| Total Liabilities | 22.4M | 28.99M | 36.46M | 4.48M | 4.93M |
| Total Equity | -17.9M | -26.07M | -33.83M | 29.66M | 11.64M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -10.08M | -7.55M | -6.33M | -12.54M | -16.35M |
| Investing | -134k | -33k | 2.9M | -77k | -311k |
| Financing | 10.17M | 6.58M | 3.83M | 41.9M | -275k |
| Market Cap | 22.88M |
| Price to Earnings Ratio | -1.18 |
| Price to Sales Ratio | 35.87 |
| Price to Cash Ratio | 1.74 |
| Price to Book Ratio | 1.96 |
| Dividend Yield | - |
| Shares Outstanding | 277.29M |
| Average Volume (1 week) | 66.08k |
| Average Volume (1 Month) | 278.45k |
| 52 Week Change | -45.90% |
| 52 Week High | 16.50 |
| 52 Week Low | 4.50 |
| Spread (Intraday) | 0.5 (5.88%) |
| Company Name | Ondine Biomedical Inc. |
| Address |
888 - 1100 melville street vancouver, british columbia V6E 4A6 |
| Website | https://ondinebio.com |
| Industry | minrls,earths-ground,treated (3295) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
